123 related articles for article (PubMed ID: 3944964)
1. The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity.
Lam YW; Arana CJ; Shikuma LR; Rotschafer JC
JAMA; 1986 Feb; 255(5):639-42. PubMed ID: 3944964
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
Moore RD; Smith CR; Lipsky JJ; Mellits ED; Lietman PS
Ann Intern Med; 1984 Mar; 100(3):352-7. PubMed ID: 6364908
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
Garrison MW; Rotschafer JC
Ther Drug Monit; 1989; 11(2):171-5. PubMed ID: 2718222
[TBL] [Abstract][Full Text] [Related]
4. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
Arroyo JC; Milligan WL; Davis J; Mitchell D
South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
[TBL] [Abstract][Full Text] [Related]
6. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside-induced nephrotoxicity.
Wargo KA; Edwards JD
J Pharm Pract; 2014 Dec; 27(6):573-7. PubMed ID: 25199523
[TBL] [Abstract][Full Text] [Related]
8. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
Schentag JJ; Plaut ME; Cerra FB
Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
Schentag JJ; Cerra FB; Plaut ME
Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside nephrotoxicity and renal function status.
Bottemiller BL
Am J Hosp Pharm; 1986 Jan; 43(1):66, 68. PubMed ID: 3953586
[No Abstract] [Full Text] [Related]
11. An approach to forecast aminoglycoside-related nephrotoxicity from routinely collected clinical data.
Kubota K; Suganuma T; Sasaki T; Ishizaki T
Ther Drug Monit; 1988; 10(4):410-20. PubMed ID: 3201525
[TBL] [Abstract][Full Text] [Related]
12. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
Kumin GD
JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside nephrotoxicity in obstructive jaundice.
Desai TK; Tsang TK
Am J Med; 1988 Jul; 85(1):47-50. PubMed ID: 3389381
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
[No Abstract] [Full Text] [Related]
15. Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 2.
Peloquin C
Antimicrob Agents Chemother; 2010 Jun; 54(6):2750-1; author reply 2752. PubMed ID: 20480959
[No Abstract] [Full Text] [Related]
16. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
Prins JM; Weverling GJ; van Ketel RJ; Speelman P
Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
[TBL] [Abstract][Full Text] [Related]
17. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
Trollfors B; Bergmark J; Hiesche K; Jagenburg R
Infection; 1984; 12(1):20-2. PubMed ID: 6142864
[TBL] [Abstract][Full Text] [Related]
18. Suggestions for monitoring patients during treatment with aminoglycoside antibiotics.
Lerner SA; Matz GJ
Otolaryngol Head Neck Surg (1979); 1979; 87(2):222-8. PubMed ID: 503492
[TBL] [Abstract][Full Text] [Related]
19. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
Smith CR; Lipsky JJ; Lietman PS
Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for toxicity in elderly patients given aminoglycosides once daily.
Paterson DL; Robson JM; Wagener MM
J Gen Intern Med; 1998 Nov; 13(11):735-9. PubMed ID: 9824518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
